Search Results - Mario P Colombo

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma by Caterina Cascini, Chiara Ratti, Laura Botti, Beatrice Parma, Valeria Cancila, Adriana Salvaggio, Cristina Meazza, Claudio Tripodo, Mario P. Colombo, Claudia Chiodoni

    Get full text
    Article


  2. 2

    Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress. by Tiziana Triulzi, Patrizia Casalini, Marco Sandri, Manuela Ratti, Maria L Carcangiu, Mario P Colombo, Andrea Balsari, Sylvie Ménard, Rosaria Orlandi, Elda Tagliabue

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  3. 3

    OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis by Patrizia Nanni, Carla De Giovanni, Alessia Burocchi, Giordano Nicoletti, Lorena Landuzzi, Arianna Palladini, Marianna Lucia Ianzano, Ivano Arioli, Mario P. Colombo, Pier-Luigi Lollini

    Published in OncoImmunology (2018-08-01)
    Get full text
    Article


  4. 4

    SPARC regulation of PMN clearance protects from pristane-induced lupus and rheumatoid arthritis by Sabina Sangaletti, Laura Botti, Alessandro Gulino, Daniele Lecis, Barbara Bassani, Paola Portararo, Matteo Milani, Valeria Cancila, Loris De Cecco, Matteo Dugo, Claudio Tripodo, Mario P. Colombo

    Published in iScience (2021-06-01)
    Get full text
    Article


  5. 5

    Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity by Sabina Sangaletti, Claudio Tripodo, Alessandra Santangelo, Nadia Castioni, Paola Portararo, Alessandro Gulino, Laura Botti, Mariella Parenza, Barbara Cappetti, Rosaria Orlandi, Elda Tagliabue, Claudia Chiodoni, Mario P. Colombo

    Published in Cell Reports (2016-09-01)
    Get full text
    Article


  6. 6

    Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma by Roberta Sulsenti, Barbara Frossi, Lucia Bongiovanni, Valeria Cancila, Paola Ostano, Irene Fischetti, Claudia Enriquez, Francesca Guana, Giovanna Chiorino, Claudio Tripodo, Carlo E. Pucillo, Mario P. Colombo, Elena Jachetti

    Published in Frontiers in Immunology (2021-03-01)
    Get full text
    Article


  7. 7

    SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities by Sabina Sangaletti, Giovanna Talarico, Claudia Chiodoni, Barbara Cappetti, Laura Botti, Paola Portararo, Alessandro Gulino, Francesca Maria Consonni, Antonio Sica, Antonio Sica, Giovanni Randon, Massimo Di Nicola, Claudio Tripodo, Mario P. Colombo

    Published in Frontiers in Immunology (2019-06-01)
    Get full text
    Article


  8. 8

    A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas by Claudio Tripodo, Federica Zanardi, Fabio Iannelli, Saveria Mazzara, Mariella Vegliante, Gaia Morello, Arianna Di Napoli, Alessandro Mangogna, Fabio Facchetti, Sabina Sangaletti, Claudia Chiodoni, Alison VanShoiack, Anand D. Jeyasekharan, Stefano Casola, Mario P. Colombo, Maurilio Ponzoni, Stefano A. Pileri

    Published in iScience (2020-10-01)
    Get full text
    Article


  9. 9

    Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards by Vincenzo Bronte, Sven Brandau, Shu-Hsia Chen, Mario P. Colombo, Alan B. Frey, Tim F. Greten, Susanna Mandruzzato, Peter J. Murray, Augusto Ochoa, Suzanne Ostrand-Rosenberg, Paulo C. Rodriguez, Antonio Sica, Viktor Umansky, Robert H. Vonderheide, Dmitry I. Gabrilovich

    Published in Nature Communications (2016-07-01)
    Get full text
    Article


  10. 10

    CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer by Lorenzo Castagnoli, Alma Franceschini, Valeria Cancila, Matteo Dugo, Martina Bigliardi, Claudia Chiodoni, Paolo Toneguzzo, Viola Regondi, Paola A. Corsetto, Filippo Pietrantonio, Serena Mazzucchelli, Fabio Corsi, Antonino Belfiore, Andrea Vingiani, Giancarlo Pruneri, Francesca Ligorio, Mario P. Colombo, Elda Tagliabue, Claudio Tripodo, Claudio Vernieri, Tiziana Triulzi, Serenella M. Pupa

    Get full text
    Article


  11. 11

    Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer by Lorenzo Castagnoli, Alma Franceschini, Valeria Cancila, Matteo Dugo, Martina Bigliardi, Claudia Chiodoni, Paolo Toneguzzo, Viola Regondi, Paola A. Corsetto, Filippo Pietrantonio, Serena Mazzucchelli, Fabio Corsi, Antonino Belfiore, Andrea Vingiani, Giancarlo Pruneri, Francesca Ligorio, Mario P. Colombo, Elda Tagliabue, Claudio Tripodo, Claudio Vernieri, Tiziana Triulzi, Serenella M. Pupa

    Get full text
    Article


  12. 12

    ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion by Barbara Bassani, Giorgia Simonetti, Valeria Cancila, Antonio Fiorino, Marilena Ciciarello, Annamaria Piva, Arman Mandegar Khorasani, Claudia Chiodoni, Daniele Lecis, Alessandro Gulino, Eugenio Fonzi, Laura Botti, Paola Portararo, Massimo Costanza, Marta Brambilla, Giorgia Colombo, Juerg Schwaller, Alexandar Tzankov, Maurilio Ponzoni, Fabio Ciceri, Niccolò Bolli, Antonio Curti, Claudio Tripodo, Mario P. Colombo, Sabina Sangaletti

    Published in Cell Reports (2024-02-01)
    Get full text
    Article


Search Tools: